Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment

NCT01002547 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

105

Enrollment

FED

Sponsor class

Conditions

Nonalcoholic Steatohepatitis

Interventions

DRUG: pioglitazone-placebo
DRUG: pioglitazone
DIETARY_SUPPLEMENT: Vitamin E
DRUG: pioglitazone-placebo
DIETARY_SUPPLEMENT: Vitamin E
DRUG: Vitamin E-placebo

Sponsor

VA Office of Research and Development